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ABSTRACT
Telemedicine technologies and services allow today’s
ophthalmic clinicians to remotely diagnose, manage and
monitor several ophthalmic conditions from a distance.
But is this the case for glaucomas? There has been a
proliferation of telemedicine friendly devices in recent
years that improves the capabilities of the clinician in
managing glaucomas. The existing instruments still need
to align themselves with accepted industry standards.
There are successful programmes running in several
areas of the world. The safety and efﬁcacy of these
programmes needs further exploration. The inability of a
single device or test to diagnose glaucomas satisfactorily
has also hampered progress in remotely diagnosing
these conditions. There is, however, signiﬁcant potential
for telemedicine-friendly devices to remotely monitor the
progress of glaucoma and, thereby, reduce some of the
workload on an overstretched health service.
INTRODUCTION
Telemedicine, or telehealth, refers to the practice of
medicine at a spatial and/or temporal distance by
exchanging medical information via electronic com-
munications.1 The key aspect in the development
of telemedicine is the constantly evolving inter-
action between medicine and information and com-
munication technology (ICT). Given that ICT can
support data collection and exchange, this can
enable improved communication and integration of
clinical services. Radiology has been at the van-
guard of telemedicine; electronic transfer of digital
images between radiological departments is now
standard practice because the images do not dimin-
ish in quality with transfer.
Telemedicine principles have already been suc-
cessfully applied within ophthalmology in the
National Health Service Diabetic Retinopathy
Screening Programme and retinopathy of prematur-
ity screening. A ‘store and forward’ approach is
used whereby images/data acquired at one site are
transferred to a remote grader who views these
images at a different time. Alternative approaches
include remote monitoring and interactive tele-
medicine where self-testing allows clinicians to
monitor a patient, and real-time interaction may
occur between the clinician and the patient.
Glaucoma management increasingly involves use
of devices that are perceived to be ‘telemedicine-
friendly’. Automated perimetry, tonometry, corneal
pachymetry, imaging of the optic disc, nerve ﬁbre
layer and anterior segment, may all generate digital
outputs that can be transferred electronically and
viewed remotely.
This review outlines the validity of remote
review with current technology and work reported
to date using remote technology in glaucoma detec-
tion and management. Papers included in this
review were identiﬁed through pubmed searches
using the keywords ‘teleophthalmology’, ‘teleglau-
coma’, ‘glaucoma imaging’, ‘glaucoma screening’,
‘glaucoma case detection’, ‘glaucoma progression’
and ‘IOP measurement’; references in English were
included.
TECHNOLOGY: STANDARDISATION AND
INTEGRATION
For any telemedicine/telehealth system to be imple-
mented it is vital that open information exchange
standards are used. Table 1 illustrates the principal
standards and associated organisations that exist in
this ﬁeld.
While some glaucoma devices can already be con-
ﬁgured to automatically upload data in a standar-
dised format, others cannot (eg, older Goldmann
applanation tonometers and corneal pachymeters).
Standardised digital interfaces for most monitoring
devices are awaited, and until such point, manual
data entry into the electronic patient record will be
required.
POLITICAL CLIMATE AND RATIONALE FOR
TELEGLAUCOMA
In general, regulatory, legal and ﬁnancial issues are all
barriers to adoption of telehealth. The political
momentum in the UK supporting ‘telehealth’ is
strong, with the prime minister, David Cameron,
pledging that up to 3 million people with chronic
conditions will be managed using telehealth technol-
ogy, funded through the government’s Life Sciences
Strategy.15 The principal cited reason was the success
of the Whole Systems Demonstrator (WSD) trial.
This was a cluster randomised trial conducted in
3230 people with diabetes, chronic obstructive pul-
monary disease and heart failure.16 Subjects rando-
mised to the telehealth arm underwent home
self-monitoring during allotted sessions using instru-
ments, such as glucometers, pulse oximeters, weigh-
ing scales and symptom questionnaires. This
approach led to a lower 12-month admission rate and
mortality at 12 months. Recently, however, doubts
have been raised as to whether the strategy was cost
effective when compared with standard care.17
Primary open-angle glaucoma (POAG) is a
chronic condition with a prevalence of 2% in
people over 40 years of age,18–22 rising to over
10% in some populations over 80 years of age.22 23
There is a signiﬁcant burden of disease, with up to
10% of UK blind registrations being attributable to
glaucomas.24 Hospital eye services are considerably
challenged by the inﬂux of new glaucoma referrals,
while continuing to monitor existing stable
patients. There is, therefore, an argument to try
and minimise hospital visits by reviewing stable
glaucoma patients outside the hospital clinic
setting.
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Table 1 Summary of the current healthcare technological integration strategies and standards
Standard/organisation Nature Purpose Detail
HL7 (Health Level 7)2 International non-profit organisation Involved in developing international open health informatics standards Develops messaging, clinical document and other health informatics
interoperability standards to enable exchange of healthcare information
HL7- V.2.X, V.3.0, CDA3 HL7 V.2.X, V.3.0 and Clinical Document
Architecture.
These standards developed by HL7 enable
information exchange and structuring of
clinical documents
V2.X and 3.0 are messaging standards and can be used when real-time
transfer of information is needed.
HL7 V3 CDA allows representation and processing of clinical documents that
makes it machine and human readable.
The CDA document can include free text, images and other multimedia
content. Telemedicine consultations can involve clinicians or patients sending
patient summaries, referral letters or other clinical documentation between
multiple entities and the CDA document can ensure interoperability even in the
presence of legacy systems
Depending on the requirements of the telemedicine system, both these
standards can coexist.
Several clinical information systems have adopted HL7 and other standards
are in the process of conversion but there needs to be wider acceptance to
ensure complete interoperability
DICOM (Digital Imaging
and Communication in
Medicine)4
Administered by the Medical Imaging and
Technology Alliance, a division of the National
Electrical Manufacturers Association (NEMA)
International standard developed to ensure interoperability between imaging
systems.
DICOM has existed as a standard since 1993, and this has been one of the key
developments in enabling the communication of radiological tests
Most new devices used in ophthalmology today have DICOM compatibility.
This allows the device to integrate seamlessly with an electronic health
record system and with a Picture Archiving and Communication System
(PACS).
Digital transfer of optic disc photography has been shown to have no
significant effect on image quality and does not impact upon the clinician’s
ability to interpret the images5
ANSI (American National
Standards Institute)6 H.32x
Private non-profit standards development
organisation
H.32x is a standard that enables video conferencing and allows clinicians and
patients to communicate with each other regardless of the video conferencing
hardware used, and are needed where real-time telemedicine
video-conferencing applications are required
Continua Health Alliance7 Non-profit open industry alliance of leading
healthcare technology companies and device
manufacturers.
The alliance consists of fitness/wellness device
and chronic disease personal health
management device manufacturers
Members of this alliance select appropriate standards and establish strict
interoperability guidelines that allow these devices and home monitoring
systems to share information.
Personal health and home monitoring devices which have undergone the
Continua Certification Process should collect and exchange the health and
wellness information with other certified devices in an efficient manner
The data collected with the help of these telehealth devices can then be
exchanged with the patient’s care team using Integrating the Healthcare
Enterprise (IHE) Profiles developed for this purpose.
The ISO/IEEE 11 073 Personal Health Data (PHD) Standards developed for
interoperability of personal health devices (also used by Continua Health
Alliance) does not have a device-specific standard for self-tonometry
devices.8 9
None of the self-tonometry or IOP home monitoring devices are certified by
Continua Health Alliance at present.10
Development of device-specific standards and active participation of
self-tonometry device manufacturers in organisations facilitating
interoperability will make these devices more user friendly, interoperable
and enable wider adoption
IHE11 Integrating the healthcare enterprise.
International consortium of clinicians, vendors
and health informatics professionals
Promotes the use of existing standards (DICOM, HL7, web services, etc.)
IHE working group formulates technical framework specifications called IHE
Profiles which allow vendors to independently develop solutions that meet
requirements of this framework.
These profiles address common yet difficult interoperability issues affecting
healthcare information exchange and interoperability.
IHE also participates in testing and validation of these profiles and vendor
implementations so that they work in real-life scenarios, and actively promotes
their use.
IHE accelerates adoption of Electronic Health Records and allows exchange of
information between disparate clinical environments and information systems
and helps address the problem of information silos
There are 8 clinical domains covered by IHE, and ophthalmology is one of
them.12 Telemedicine practitioners should consider IHE Integration
Statements during implementation that describes the conformance of a
particular product to the domain-specific technical framework (eg, IHE Eye
Care Technical Framework).
Most glaucoma imaging device manufactures are members of IHE and have
produced IHE Integration Statements (eg, Basic Eye Care Workflow).13
IHE Eye Care Planning Committee has prioritised glaucoma and is currently
working on producing CDA profiles specific for glaucoma and other
subspecialities in the coming years.14
This should solve some of the interoperability problems within glaucoma
clinical management and subsequently improve teleglaucoma applicability,
although further work is needed before all interoperability issues are
addressed
CDA, clinical document architecture; IOP, intraocular pressure.
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Most reported teleglaucoma schemes have been used in
remote areas where speciﬁc glaucoma expertise is not avail-
able.25–27 The number of staff at a remote site can be mini-
mised, with potentially a ‘dedicated’ technician overseeing
tonometry, imaging and perimetry at each testing station. Any
potential teleglaucoma scheme’s management team will need to
devise a speciﬁc training programme and competency assess-
ments (along with continuing education and appraisal) for any
staff undertaking testing at a remote site.
TELEGLAUCOMA-FRIENDLY TECHNOLOGY
Intraocular pressure measurement
Therapies for glaucomas are predominantly focused on lowering
intraocular pressure (IOP), hence, this is a crucial element of
any follow-up assessment. For detection of disease, IOP mea-
surements above 21 mm Hg have a reported sensitivity of 47%
and speciﬁcity of 92% for detecting POAG, and this does not
improve when conﬁned to high-risk groups.28
Goldmann applanation tonometry (GAT) is now available
with a digital output (AT 900D, Haag-Streit International,
Koeniz, Switzerland). Non-contact tonometers (NCT), rebound
tonometers (iCare, Helsinki, Finland) and hand-held applana-
tion tonometers (Tonopen, Reichert, Depew, New York, USA)
have the advantage that less skilled operators can use them
effectively, and they are portable. Repeated measurements with
GAT are, however, more reproducible than automated methods
of IOP measurement.29 Non-contact methods may be subject to
systematic bias (rebound tonometry was found to overestimate
IOP by a mean of 2.3 mm Hg30 up to 3.4 mm Hg31 compared
to GAT) non-systematic bias (there is a tendency for tonopen to
underestimate IOP at high IOP levels32–35) and other sources of
bias (pneumotonometry and rebound tonometry are prone to
overmeasurement with increasingly thicker corneas31 36 37).
However, recent studies have shown marked improvement in
measurements between rebound tonometers and GAT.38
Since the management of IOP is relative in each individual,
provided the same method of assessment is used for compari-
son, systematic bias should be of less importance. Of greater
importance is non-systematic bias and the reproducibility of
results. Automated measurement devices are not necessarily
interchangeable substitutes for GAT.
In due course, home monitoring may become a possibility.
iCare ONE has been developed speciﬁcally for home use.39 40
There is also a contact lens sensor device for measuring IOP
(Sensimed Triggerﬁsh CLS, Sensimed AG, Lausanne,
Switzerland).41 A systematic review and meta-analysis of studies
comparing GAT with other tonometers revealed that NCT had
the least amount of variability in measurements, and the
Ocuton-S (an applanation ‘self ’ tonometer) had the lowest
agreement with GAT.42 The review also showed that rebound
tonometers had better agreement with GAT than Ocuton-S, but
still lower than NCT. They identiﬁed the need for further evi-
dence comparing tonometers and standardisation of reporting
to better assess the results of studies. Ocuton S*TT-MV, a recon-
ﬁgured version of the Ocuton S has apparent improved func-
tionality.43 However, there remains an inconsistent range of
differences in measurement as compared with GAT among
patients performing self-tonometry.43 44 Other innovations
enabling self-tonometry are currently under development.45 46
In future, adaptations to smartphones may enable patients to
automatically record their IOP and transmit the data to
clinicians.47
Optic disc and retinal nerve ﬁbre layer imaging
Disc photographs
Since glaucomas are progressive optic neuropathies it is impera-
tive that teleglaucoma strategies should employ a method for
structural (optic disc and/or nerve ﬁbre layer) assessment.
Stereoscopic disc images have been regarded as the reference
standard for clinical trials in glaucoma where a high degree of
reproducibility has been achieved using dedicated reading
centres.48 Bergua et al49 have demonstrated that stereoscopic
optic disc images may be transferred via the internet using a per-
sonal computer equipped with stereoscopic liquid crystal display
shutter glasses, or using an LCD display in combination with
red-cyan goggles for viewing.
Subjective interpretation of optic disc stereophotographs can
be highly variable. In a study of sequential stereophotographs,
three expert glaucoma specialists could only achieve a ‘slight to
fair’ agreement as regards structural progression.50 In a study of
European ophthalmologists, asked to assess stereoscopic slides
from healthy and glaucoma eyes, an overall ‘diagnostic accuracy’
of 80.5% was achieved.51 In that study, the best performing algo-
rithms for the Heidelberg Retina Tomograph (HRT) (Heidelberg
Engineering, Heidelberg, Germany) and GDx (Carl Zeiss
Meditec, Dublin, California, USA) generally outperformed most
clinicians in terms of diagnostic accuracy. Appropriate training or
engagement of a reading centre, should be considered if stereo-
photographs are to be used in a teleglaucoma scheme.
HRT and optical coherence tomography: glaucoma ‘classiﬁcation’
The pre-eminent imaging modalities in glaucoma are confocal
scanning laser ophthalmoscopy (CSLO, as performed using the
HRT) and optical coherence tomography (OCT). A third
modality, scanning laser polarimetry (GDx and its derivatives,
Carl Zeiss Meditec, Dublin, California, USA), is as effective in
terms of glaucoma ‘classiﬁcation’ as HRT and OCT, but has
largely been superseded by OCT technology in terms of clinical
practice and in active research.
HRT uses two classiﬁcation algorithms—the Moorﬁelds
Regression Analysis (MRA) and the Glaucoma Probability Score
(GPS). MRA is based on the understanding that rim area varies
with disc size, may decline with advancing age and may narrow
in any sector of the disc in glaucoma. Very large and very small
discs confound MRA.52 53 Atypical optic nerve head (ONH)
morphology may lead to such discs falling outside the normative
range without necessarily being glaucomatous. Sensitivities of
58–84% and speciﬁcities of 81–96% have been reported
depending on inclusion and cut-off criteria.54–56
GPS uses a mathematical model of ONH shape to discrimin-
ate between normal and glaucomatous eyes.57 The method is
operator-independent as it does not require contour line place-
ment. GPS does not confer any advantage over the MRA in
terms of sensitivity and speciﬁcity.52 58 There is a dependency
on disc size for MRA and GPS classiﬁcation.52
Several studies have demonstrated the performance of time
domain OCT (TDOCT) in discriminating between normal and
glaucomatous eyes.59–66 Comparisons between TDOCT, CSLO
and scanning laser polarimetry have failed to identify a signiﬁ-
cant advantage of one device over another.61 63 67 A compari-
son between the retinal nerve ﬁbre layer (RNFL), ONH and
macular thickness parameters of the STRATUSOCT (Carl Zeiss
Meditec) found that RNFL thickness and optic nerve head para-
meters had similar performance in differentiating between
healthy and glaucomatous eyes and both outperformed macular
thickness parameters.60 In all these studies, performance was
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assessed using well-deﬁned case controls with established repeat-
able glaucomatous visual ﬁeld defects, a scenario that is much
more clear-cut than is usually encountered in the normal clinical
setting.
A large number of studies have now assessed the ‘diagnostic’
capability of the more recently available spectral domain OCT
(SDOCT) devices, and most of these have made a comparison
with the performance of TDOCT.68–75 In all cases, SDOCT has
been found to have a good diagnostic capability but no major
advantage over TDOCT.68 71–75
The macula contains approximately 50% of all retinal ganglion
cells,76 hence macular thickness may be useful for glaucoma diag-
nosis.77 78 The RNFL, the ganglion cell layer and the inner plexi-
form layer together make up the ganglion cell complex (GCC).
GCC has signiﬁcantly higher diagnostic power than macular
thickness as measured by SDOCT or TDOCT, and the best per-
forming GCC parameters have been found to be equivalent to
mean RNFL thickness as measured by TDOCT.79 80
OCT technology is now also used widely for the assessment
of the anterior segment, and this could potentially be used as a
proxy test for gonioscopy. OCT cannot pick up features, such as
peripheral anterior synechiae, neovascularisation or pigmenta-
tion that are detectable by gonioscopy.
HRT and OCT: monitoring change
The current HRT3 software features two progression algo-
rithms, trend analysis and topographical change analysis (TCA).
Interpretation of the trend is empirical and a ‘rate’ of change
cannot be generated. The importance of estimating a rate of
change is highlighted by the results of the CSLO Ancillary Study
to the Ocular Hypertension Treatment Study.81 A ﬁve times
faster rate of rim loss was identiﬁed in eyes converting to glau-
coma than those that did not. TCA assesses progression by
measuring changes in the height of superpixels generating a
‘change probability map’ with red pixels representing signiﬁcant
height depression.82 TCA tends to identify more subjects as pro-
gressing than stereophotographic assessment.83 TCA has also
been shown to be predictive of future visual ﬁeld damage.84
The rapidity by which OCT technology is evolving
means there are a few longitudinal studies investigating
progression.85–88 In teleglaucoma, it may therefore be preferable
to employ stereophotographs and a semiautomated imaging
technology. Stereophotographs are largely ‘future-proof ’, but
they lack automated quantiﬁcation and progression algorithms,
of which HRT TCA is the most mature and well established.
Functional testing
Static automated perimetry (SAP) is the most widely accepted
functional test for the evaluation of glaucoma. SAP invariably
requires a degree of patient learning for reliable performance
and it is time consuming, even when using the Swedish
Interactive Thresholding Algorithm (SITA). Ideally, for teleglau-
coma purposes, a functional test should be easy to use and
quick in order to maintain a high throughput. Objective (elec-
trodiagnostic) perimetry would, therefore, be impractical.
Frequency doubling technology (FDT), however, may offer a
realistic alternative to SAP. Studies report sensitivities for FDTof
between 35% and 93% in early to moderate glaucoma, greater
than 97% in severe glaucoma, with a speciﬁcity of 90% for
early glaucoma and greater than 97% for advanced disease.89–91
FDT may detect glaucomatous visual ﬁeld loss earlier than
SAP,92 but learning effect remains a problem in subjects without
prior perimetric experience.93 Despite these advantages, SAP’s
smaller test-retest variability and larger dynamic range make it
currently the optimal choice for monitoring glaucomatous
visual ﬁeld progression.94 Some newer perimetric techniques,
such as the Moorﬁelds Motion Displacement Test, are being
developed for use on multiple computer monitor platforms.95 It
is conceivable that perimetry will become available for use in
the domiciliary setting.
Clinicians are much better at detecting ﬁeld progression when
their decision making is augmented by using a computer algo-
rithm.96 Event analyses ascribe progression when a predeter-
mined threshold has been achieved. The native event analysis
for the Humphrey Field Analyser (HFA, Carl Zeiss Meditec,
Dublin, California, USA), Guided Progression Analysis (GPA), is
based on the strategy used in the Early Manifest Glaucoma
Treatment study.97 Trend analyses monitor the behaviour of a
speciﬁc parameter over time, allowing a rate of change to be cal-
culated. A ‘global’ trend analysis, that monitors change in the
visual ﬁeld index (VFI) over time, is included in the GPA
package. An alternative approach is to perform pointwise linear
regression analysis which is the technique adopted by
PROGRESSOR (Medisoft, Leeds, UK). Trend analyses provide
better receiver operator characteristic curves than event ana-
lyses.98 From a teleglaucoma perspective, there is a good argu-
ment for adopting external software, such as PROGRESSOR, as
analysis is performed on a different computer from the perim-
eter following data transfer. This overcomes the issue of lack of
Digital Imaging and Communication in Medicine (DICOM)
compatibility when using older perimeters.
TELEGLAUCOMA IN PRACTICE
In glaucoma management and case detection, the outcome of
most interest is the number of false negatives, that is, the
number of those who are true cases or are progressing cases that
are not detected. Detection of false negatives is a major chal-
lenge. Both outcomes are relatively rare. The normal method-
ology to approach such a scenario is to undertake studies
determining the sensitivity and speciﬁcity using an enriched
population. Sensitivity and speciﬁcity are independent of preva-
lence, therefore, improved estimates may be obtained by having
large proportions of outcomes of interest in the study group.
There is a notable lack of such assessments, meaning that there
is a risk of accepting an unsafe system. If glaucoma has a preva-
lence of 2%, screening 6000 would yield 120 cases. Were only
80 cases detected, the system could be hailed a success, and yet,
there are 40 cases undetected. A major factor in favour of
decreasing false negatives in chronic disease screening is the
opportunity for a ‘second bite at the cherry’ with repeat screen-
ing over time. All these issues are, as yet, inadequately explored.
The proportion of false positives is also of interest, but much
more easily determined.
Regular monitoring
There are a few published reports of teleglaucoma applied to
routine care. The ﬁrst reported teleglaucoma pilot study was
undertaken in Finland, a country where large remote areas have
had a chronic lack of ophthalmologists.25 The study used a
video slit lamp, an automated perimeter and a non-mydriatic
fundus camera, with real-time videoconferencing. A group in
Canada has recently described a strategy to service people with,
or at risk of, glaucoma in the rural setting and living near the
university eye centre.26 The authors describe four main compo-
nents to their service: enthusiastic staff, secure reliable software,
appropriate hardware (a minimum of retinal camera, IOP,
central corneal thickness and either FDT or HFA), and national
guidelines for glaucoma management. Huatala and colleagues
Review
1608 Strouthidis NG, et al. Br J Ophthalmol 2014;98:1605–1611. doi:10.1136/bjophthalmol-2013-304133
group.bmj.com on June 5, 2015 - Published by http://bjo.bmj.com/Downloaded from 
describe a teleophthalmology mobile unit that provides diabetic
retinopathy screening and follow-up of stable glaucoma patients
in Northern Finland.27 Patients undergo visual ﬁeld testing
using HFA and digital fundus photography. A nurse measures
IOP and compares the measurement to a preset target. Images
and visual ﬁelds are assessed ofﬂine by the glaucoma specialist.
Online help is available by telephone. A similar approach is
being applied within the UK in urban and rural centres. The
Newmedica glaucoma service began at Bristol Eye Hospital in
2007 and has provided nearly 100 000 glaucoma review
appointments to date from eight mobile sites. The service uses a
proprietary electronic medical record software called Electronic
Medical Management Application (EMMA), which allows
online virtual reviewing over a secure internet connection. An
optometrist and two technicians man each mobile clinic. The
patient has visual acuity and HFA data collected. The optom-
etrist then takes a history, examines the patient (including
pachymetry and GAT), and acquires a dilated fundus photo-
graph (monoscopic) or HRT image. All data are uploaded into
EMMA including archive ﬁelds and disc images. At the end of
the consultation, the optometrist provides a provisional manage-
ment outcome made ﬁnal within ﬁve working days after review
of the data online by a glaucoma specialist working online in a
virtual clinic. Once the outcome has been decided, the clinic
software automatically writes to the patient and their general
practitioner, and the next appointment is booked.
Detection of new cases
A systematic review of diagnostic tests for glaucoma failed to iden-
tify a particular advantage of a single test for the purposes of glau-
coma screening.99 Indeed, a Health Technology Assessment
suggested that screening for open-angle glaucoma would not be
cost effective although targeted screening of subjects in high-risk
groups (eg, family history, black ethnicity) might be worthwhile.100
A number of groups have tried to apply a targeted approach to
glaucoma screening using teleglaucoma.
In Rotterdam, 10 community optometric practices were
equipped with GDx, and patients considered ‘at risk’ were
offered imaging.101 The images and clinical details were trans-
ferred to the eye hospital for assessment. From 1729 patients
screened, 467 (27%) were called to the hospital and 80 new
cases of glaucoma were identiﬁed giving a positive predictive
value of only 18%. In a study undertaken in Tasmania, visual
acuity, autorefraction, SAP, IOP measurement using the Tonopen
and stereoscopic disc photographs were all acquired at remote
sites then amalgamated into a summary PDF ﬁle that was trans-
ferred electronically to a glaucoma specialist.102 First-degree
relatives of patients with a conﬁrmed diagnosis of glaucoma
were screened and one new case of glaucoma was identiﬁed for
every 19 participants. There was, however, a very low take-up
of the scheme among subjects at risk.
Glaucoma data archiving
Managing glaucoma patients via a remote clinic necessitates the
electronic archiving of historic clinical data, including visual
ﬁelds and images. Visual ﬁeld data and images can be electronic-
ally assimilated into the teleglaucoma notes relatively easily.
However, archiving paper notes can present a signiﬁcant
problem where the patient population has been under the care
of a clinic for many years, and where paper notes are commen-
surably bulky. Three potential methods for incorporating his-
toric notes into a paperless teleglaucoma clinic include:
▸ To make historic paper notes available for the ﬁrst few visits
to the teleglaucoma clinic to allow an overlap, whereby the
teleglaucoma notes progressively replace the paper notes
(which are eventually archived).
▸ To make a full electronic copy of the paper notes and incorp-
orate that archive into the teleglaucoma notes (usually in the
form of PDF documents).
▸ To manually transcribe a summary of the salient events from
the paper history into the electronic notes.
Each approach represents a compromise. Even the option of
scanning the old notes in their entirety can overload the tele-
glaucoma clinic with data which can be hard to identify and is
often of minimal value.
Postoperative review
Another area where telehealth may be useful is in postsurgical
management. Crowston et al103 assessed the interobserver
agreement for clinical signs in post-trabeculectomy eyes when
evaluated by real-time video images compared with face-to-face
consultation. Remote assessment provided high levels of agree-
ment for bleb vascularity, anterior chamber depth, and the exist-
ence of a bleb leak; it was much more variable for bleb height
and bleb wall thickness. More recently, a Japanese group has
similarly shown images acquired using a remote controlled slit
lamp to be of use in postoperative management.104
CONCLUSIONS
Glaucomas remain enigmatic conditions in which a diagnosis
cannot consistently be made using a single test, or indeed a
battery of tests. The proliferation of teleglaucoma-‘friendly’
devices, for IOP measurement and quantitative disc assessment
have not necessarily increased our ability to detect glaucomas in
the absence of a face-to-face consultation. In that regard, tele-
glaucoma is perhaps not yet ‘ready to go’. These technologies
are, however, likely to be useful in the monitoring of patients
with an established diagnosis of glaucoma, and it is in this
context that a few teleglaucoma schemes have already become
successfully established. Given the increasing age of the popula-
tion, and the constraints upon already stretched hospital eye ser-
vices, it is likely that reliance on teleglaucoma will increase. This
may be despite the fact that the diagnostic and monitoring cap-
abilities of currently available technologies will not necessarily
meet the ambitions of the teleglaucoma schemes from the
outset. There is a strong case for further robust studies investi-
gating the positive and negative predictive power of all systems
of glaucoma detection and monitoring.
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